title: The Pediatric Epilepsy Side Effects Questionnaire: Establishing clinically meaningful change.
abstract: The present study extends the utility of the Pediatric Epilepsy Side Effects Questionnaire (PESQ) by determining distribution-based minimally clinically important difference (MCID) scores. Participants (N=682) were youth (ages 2-25) with newly diagnosed and chronic epilepsy pooled from research and clinical data in the Comprehensive Epilepsy Center. Caregivers completed the PESQ. Demographic and medical data were extracted from medical chart reviews or via a questionnaire. The MCIDs, which are the standard errors of measurement for each scale, for the entire sample were as follows: Cognitive=4.66, Motor=4.67, Behavior=8.05, General Neurological=7.41, Weight=9.58, and Total Side Effects=3.25. Additionally, MCIDs for patients with new-onset (<12months) epilepsy on monotherapy, new-onset epilepsy on polytherapy, chronic epilepsy on monotherapy (>12months), and chronic epilepsy on polytherapy were calculated. Results from the present study extend the utility of the PESQ by providing clinicians and researchers an enhanced understanding about clinically meaningful changes in side effect profiles across the pediatric epilepsy spectrum. These data can inform clinical decision-making for clinicians and researchers.
authors.affiliation: Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, USA. Electronic address: katherine.junger@cchmc.org.
authors.forename: Katherine W
authors.initials: KW
authors.lastname: Junger
authors.affiliation: Division of Neurology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, USA. Electronic address: diego.morita@cchmc.org.
authors.forename: Diego
authors.initials: D
authors.lastname: Morita
authors.affiliation: Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, USA. Electronic address: avani.modi@cchmc.org.
authors.forename: Avani C
authors.initials: AC
authors.lastname: Modi
mesh_terms: D000293:Adolescent; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis; D004827:Epilepsy / Q000175:diagnosis* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D011795:Surveys and Questionnaires / Q000592:standards; D055815:Young Adult
chemical_list: D000927:Anticonvulsants
keywords: Antiepileptic drugs; Children; MCID; Patient-reported outcome; Seizures; Side effects
references.citation: J Eval Clin Pract. 2000 Feb;6(1):39-49
references.pmid: 10807023
references.citation: Epilepsia. 2014 Jun;55(6):866-77
references.pmid: 24673687
references.citation: Neurology. 2012 Sep 18;79(12):1252-8
references.pmid: 22875082
references.citation: Int J Pediatr Obes. 2011 Jun;6(2-2):e94-6
references.pmid: 20883106
references.citation: JAMA. 2011 Apr 27;305(16):1669-76
references.pmid: 21521848
references.citation: Diabetes Care. 2013 Jul;36(7):1891-7
references.pmid: 23340884
references.citation: J Pediatr Psychol. 2011 May;36(4):466-75
references.pmid: 21278379
references.citation: J Clin Epidemiol. 1999 Sep;52(9):861-73
references.pmid: 10529027
references.citation: J Clin Epidemiol. 1994 Jan;47(1):81-7
references.pmid: 8283197